Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
55
BLFS Quote, Financials, Valuation and Earnings
Last price:
$23.24
Seasonality move
:
-0.62%
Day range:
$22.14 - $23.09
52-week range:
$19.10 - $29.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.93x
P/B ratio:
3.11x
Volume:
359.3K
Avg. volume:
350.7K
1-year change:
-19.35%
Market cap:
$1.1B
Revenue:
$82.3M
EPS (TTM):
-$0.07
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BLFS
BioLife Solutions, Inc.
|
$24M | $0.01 | 5.9% | -98.07% | $32.44 |
|
AORT
Artivion, Inc.
|
$116.4M | $0.18 | 16.97% | -75% | $51.43 |
|
DXCM
DexCom, Inc.
|
$1.3B | $0.65 | 13.43% | 74.85% | $85.46 |
|
EW
Edwards Lifesciences Corp.
|
$1.5B | $0.62 | 12.89% | 16.77% | $96.50 |
|
NTRB
Nutriband, Inc.
|
$765K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$2.2B | $2.40 | 8.14% | 103.71% | $102.65 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BLFS
BioLife Solutions, Inc.
|
$22.84 | $32.44 | $1.1B | -- | $0.00 | 0% | 10.93x |
|
AORT
Artivion, Inc.
|
$37.52 | $51.43 | $1.8B | 187.79x | $0.00 | 0% | 3.95x |
|
DXCM
DexCom, Inc.
|
$72.80 | $85.46 | $28B | 34.78x | $0.00 | 0% | 6.33x |
|
EW
Edwards Lifesciences Corp.
|
$78.98 | $96.50 | $45.8B | 42.63x | $0.00 | 0% | 7.63x |
|
NTRB
Nutriband, Inc.
|
$4.00 | $15.00 | $48.6M | -- | $0.00 | 0% | 19.96x |
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$98.25 | $102.65 | $19.5B | 27.73x | $0.24 | 0.98% | 2.37x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BLFS
BioLife Solutions, Inc.
|
5.52% | 0.391 | 1.69% | 3.31x |
|
AORT
Artivion, Inc.
|
36.5% | 2.269 | 11.81% | 1.52x |
|
DXCM
DexCom, Inc.
|
33.6% | 1.718 | 5.44% | 1.51x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.006 | 1.21% | 2.86x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.122 | 0.32% | 7.07x |
|
ZBH
Zimmer Biomet Holdings, Inc.
|
37.18% | -0.699 | 42.19% | 0.89x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BLFS
BioLife Solutions, Inc.
|
$17.2M | -$89K | -4.73% | -5.11% | -0.32% | $2.8M |
|
AORT
Artivion, Inc.
|
$69.7M | $7.2M | 1.44% | 2.6% | 6.19% | -$7.9M |
|
DXCM
DexCom, Inc.
|
$792.7M | $323M | 17.33% | 33.68% | 25.64% | $192.1M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $370.3M | 9.63% | 13.19% | 23.59% | $516.2M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$1.5B | $287.8M | 3.54% | 5.61% | 12.83% | $658.7M |
BioLife Solutions, Inc. vs. Competitors
-
Which has Higher Returns BLFS or AORT?
Artivion, Inc. has a net margin of 2.21% compared to BioLife Solutions, Inc.'s net margin of 2.09%. BioLife Solutions, Inc.'s return on equity of -5.11% beat Artivion, Inc.'s return on equity of 2.6%.
Company Gross Margin Earnings Per Share Invested Capital BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M AORTArtivion, Inc.60.06% $0.05 $705.8M -
What do Analysts Say About BLFS or AORT?
BioLife Solutions, Inc. has a consensus price target of $32.44, signalling upside risk potential of 42.05%. On the other hand Artivion, Inc. has an analysts' consensus of $51.43 which suggests that it could grow by 37.07%. Given that BioLife Solutions, Inc. has higher upside potential than Artivion, Inc., analysts believe BioLife Solutions, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLFSBioLife Solutions, Inc.9 0 0 AORTArtivion, Inc.4 1 0 -
Is BLFS or AORT More Risky?
BioLife Solutions, Inc. has a beta of 1.924, which suggesting that the stock is 92.426% more volatile than S&P 500. In comparison Artivion, Inc. has a beta of 1.591, suggesting its more volatile than the S&P 500 by 59.114%.
-
Which is a Better Dividend Stock BLFS or AORT?
BioLife Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Artivion, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioLife Solutions, Inc. pays -- of its earnings as a dividend. Artivion, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLFS or AORT?
BioLife Solutions, Inc. quarterly revenues are $28.1M, which are smaller than Artivion, Inc. quarterly revenues of $116M. BioLife Solutions, Inc.'s net income of $621K is lower than Artivion, Inc.'s net income of $2.4M. Notably, BioLife Solutions, Inc.'s price-to-earnings ratio is -- while Artivion, Inc.'s PE ratio is 187.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioLife Solutions, Inc. is 10.93x versus 3.95x for Artivion, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLFSBioLife Solutions, Inc.10.93x -- $28.1M $621K AORTArtivion, Inc.3.95x 187.79x $116M $2.4M
-
Which has Higher Returns BLFS or DXCM?
DexCom, Inc. has a net margin of 2.21% compared to BioLife Solutions, Inc.'s net margin of 21.22%. BioLife Solutions, Inc.'s return on equity of -5.11% beat DexCom, Inc.'s return on equity of 33.68%.
Company Gross Margin Earnings Per Share Invested Capital BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M DXCMDexCom, Inc.62.93% $0.68 $4.1B -
What do Analysts Say About BLFS or DXCM?
BioLife Solutions, Inc. has a consensus price target of $32.44, signalling upside risk potential of 42.05%. On the other hand DexCom, Inc. has an analysts' consensus of $85.46 which suggests that it could grow by 17.39%. Given that BioLife Solutions, Inc. has higher upside potential than DexCom, Inc., analysts believe BioLife Solutions, Inc. is more attractive than DexCom, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLFSBioLife Solutions, Inc.9 0 0 DXCMDexCom, Inc.20 3 0 -
Is BLFS or DXCM More Risky?
BioLife Solutions, Inc. has a beta of 1.924, which suggesting that the stock is 92.426% more volatile than S&P 500. In comparison DexCom, Inc. has a beta of 1.491, suggesting its more volatile than the S&P 500 by 49.074%.
-
Which is a Better Dividend Stock BLFS or DXCM?
BioLife Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DexCom, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioLife Solutions, Inc. pays -- of its earnings as a dividend. DexCom, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLFS or DXCM?
BioLife Solutions, Inc. quarterly revenues are $28.1M, which are smaller than DexCom, Inc. quarterly revenues of $1.3B. BioLife Solutions, Inc.'s net income of $621K is lower than DexCom, Inc.'s net income of $267.3M. Notably, BioLife Solutions, Inc.'s price-to-earnings ratio is -- while DexCom, Inc.'s PE ratio is 34.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioLife Solutions, Inc. is 10.93x versus 6.33x for DexCom, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLFSBioLife Solutions, Inc.10.93x -- $28.1M $621K DXCMDexCom, Inc.6.33x 34.78x $1.3B $267.3M
-
Which has Higher Returns BLFS or EW?
Edwards Lifesciences Corp. has a net margin of 2.21% compared to BioLife Solutions, Inc.'s net margin of 4.09%. BioLife Solutions, Inc.'s return on equity of -5.11% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M EWEdwards Lifesciences Corp.78.3% $0.16 $10.9B -
What do Analysts Say About BLFS or EW?
BioLife Solutions, Inc. has a consensus price target of $32.44, signalling upside risk potential of 42.05%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.50 which suggests that it could grow by 22.18%. Given that BioLife Solutions, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe BioLife Solutions, Inc. is more attractive than Edwards Lifesciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings BLFSBioLife Solutions, Inc.9 0 0 EWEdwards Lifesciences Corp.16 12 0 -
Is BLFS or EW More Risky?
BioLife Solutions, Inc. has a beta of 1.924, which suggesting that the stock is 92.426% more volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.133%.
-
Which is a Better Dividend Stock BLFS or EW?
BioLife Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioLife Solutions, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLFS or EW?
BioLife Solutions, Inc. quarterly revenues are $28.1M, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. BioLife Solutions, Inc.'s net income of $621K is lower than Edwards Lifesciences Corp.'s net income of $64.2M. Notably, BioLife Solutions, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 42.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioLife Solutions, Inc. is 10.93x versus 7.63x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLFSBioLife Solutions, Inc.10.93x -- $28.1M $621K EWEdwards Lifesciences Corp.7.63x 42.63x $1.6B $64.2M
-
Which has Higher Returns BLFS or NTRB?
Nutriband, Inc. has a net margin of 2.21% compared to BioLife Solutions, Inc.'s net margin of -1118.87%. BioLife Solutions, Inc.'s return on equity of -5.11% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About BLFS or NTRB?
BioLife Solutions, Inc. has a consensus price target of $32.44, signalling upside risk potential of 42.05%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 275%. Given that Nutriband, Inc. has higher upside potential than BioLife Solutions, Inc., analysts believe Nutriband, Inc. is more attractive than BioLife Solutions, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLFSBioLife Solutions, Inc.9 0 0 NTRBNutriband, Inc.1 0 0 -
Is BLFS or NTRB More Risky?
BioLife Solutions, Inc. has a beta of 1.924, which suggesting that the stock is 92.426% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.886, suggesting its more volatile than the S&P 500 by 88.601%.
-
Which is a Better Dividend Stock BLFS or NTRB?
BioLife Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioLife Solutions, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BLFS or NTRB?
BioLife Solutions, Inc. quarterly revenues are $28.1M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. BioLife Solutions, Inc.'s net income of $621K is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, BioLife Solutions, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioLife Solutions, Inc. is 10.93x versus 19.96x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLFSBioLife Solutions, Inc.10.93x -- $28.1M $621K NTRBNutriband, Inc.19.96x -- $346.1K -$3.9M
-
Which has Higher Returns BLFS or ZBH?
Zimmer Biomet Holdings, Inc. has a net margin of 2.21% compared to BioLife Solutions, Inc.'s net margin of 6.15%. BioLife Solutions, Inc.'s return on equity of -5.11% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.
Company Gross Margin Earnings Per Share Invested Capital BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M ZBHZimmer Biomet Holdings, Inc.64.69% $0.70 $20.2B -
What do Analysts Say About BLFS or ZBH?
BioLife Solutions, Inc. has a consensus price target of $32.44, signalling upside risk potential of 42.05%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $102.65 which suggests that it could grow by 4.48%. Given that BioLife Solutions, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe BioLife Solutions, Inc. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BLFSBioLife Solutions, Inc.9 0 0 ZBHZimmer Biomet Holdings, Inc.6 16 2 -
Is BLFS or ZBH More Risky?
BioLife Solutions, Inc. has a beta of 1.924, which suggesting that the stock is 92.426% more volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.12%.
-
Which is a Better Dividend Stock BLFS or ZBH?
BioLife Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 0.98% to investors and pays a quarterly dividend of $0.24 per share. BioLife Solutions, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.04% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BLFS or ZBH?
BioLife Solutions, Inc. quarterly revenues are $28.1M, which are smaller than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. BioLife Solutions, Inc.'s net income of $621K is lower than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, BioLife Solutions, Inc.'s price-to-earnings ratio is -- while Zimmer Biomet Holdings, Inc.'s PE ratio is 27.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioLife Solutions, Inc. is 10.93x versus 2.37x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BLFSBioLife Solutions, Inc.10.93x -- $28.1M $621K ZBHZimmer Biomet Holdings, Inc.2.37x 27.73x $2.2B $137.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 19
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Buy
57
GLBE alert for Feb 19
Global-e Online Ltd. [GLBE] is up 4.19% over the past day.
Sell
37
ACLS alert for Feb 19
Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.
